12 Health Care Stocks Move in Wednesday's After-Market Session: Sharps Technology Leads Gainers with 76.1% Increase

On Wednesday's after-market session, several health care stocks moved. Sharps Technology's STSS stock increased by 76.1% to $16.28, while Aptorum Group's APM stock rose 26.74% to $2.18. Revolution Medicines' RVMD stock increased by 9.98% to $44.49. Meanwhile, Avidity Biosciences' RNA shares decreased by 22.7% to $35.85. Kewaunee Scientific's KEQU stock fell 16.35% to $45.75.

On Wednesday's after-market session, several health care stocks showed varied movements. Sharps Technology's (STSS) stock surged by 76.1% to $16.28, while Aptorum Group's (APM) stock rose by 26.74% to $2.18. Revolution Medicines' (RVMD) stock increased by 9.98% to $44.49, according to Investing.com Cinctive Capital Management LP Sells 23,447 Shares of Revolution Medicines, Inc. $RVMD^[3]. Meanwhile, Avidity Biosciences' RNA shares dropped by 22.7% to $35.85, and Kewaunee Scientific's (KEQU) stock fell by 16.35% to $45.75.

The NYSE Health Care Index declined by 0.8%, while the Health Care Select Sector SPDR Fund (XLV) dropped by 1.1% Sector Update: Health Care Stocks Retreat Late Afternoon^[1]. The iShares Biotechnology ETF (IBB) also decreased by 1.9%. Neurosense Therapeutics (NRSN) saw its shares jump by 18% after positive phase 2 trial results for its Alzheimer's treatment candidate, PrimeC Sector Update: Health Care Stocks Retreat Late Afternoon^[1]. Merck (MRK) canceled plans for a $1.35 billion research center in London, leading to a 0.8% drop in its shares Sector Update: Health Care Stocks Retreat Late Afternoon^[1]. Soleno Therapeutics (SLNO) fell by 15% following a report from the US Food and Drug Administration's Adverse Event Reporting System Sector Update: Health Care Stocks Retreat Late Afternoon^[1]. Actuate Therapeutics (ACTU) shares dropped by 22% after pricing an underwritten public offering Sector Update: Health Care Stocks Retreat Late Afternoon^[1].

Sharps Technology announced a strategic partnership with Web3 brand Pudgy Penguins to expand its Solana digital asset treasury exposure Sharps Technology partners with Pudgy Penguins for Solana treasury exposure^[2]. The company also entered into a Controlled Equity Offering Sales Agreement with Cantor Fitzgerald & Co. and Aegis Capital Corp., allowing it to offer and sell shares for up to $236.6 million. Additionally, the company made changes to its leadership team, appointing Paul Danner as executive chairman Sharps Technology partners with Pudgy Penguins for Solana treasury exposure^[2].

Cinctive Capital Management LP reduced its stake in Revolution Medicines, Inc. by 67.4%, holding only 11,343 shares after selling 23,447 shares in the first quarter Cinctive Capital Management LP Sells 23,447 Shares of Revolution Medicines, Inc. $RVMD^[3]. Despite this reduction, other investors such as Schonfeld Strategic Advisors LLC and Ameriprise Financial Inc. significantly increased their positions in the company. Analysts maintain a consensus rating of "Buy" for Revolution Medicines, with price targets ranging up to $99.00 Cinctive Capital Management LP Sells 23,447 Shares of Revolution Medicines, Inc. $RVMD^[3].